July 2012

Having driven generic utilization about as far as possible, plan sponsors are turning to a method of controlling drug costs that had all but disappeared. Aggressive contracting is driving this trend, but that may soon yield to evidence-based evaluation.

Michael D. Dalzell
Population management claims: The Seven Rules of Plausibility provide means to test the claims of population management vendors.
With case studies and commentary.
Al Lewis

The CEO of StayWell Health Management discusses evolving approaches to health and wellness management under health care reform

John Marcille

Advanced therapy management may lead to physician acceptance of additional medications infused at home

Tom Reinke

This study verifies, as defined by current guidelines, that initial treatment with fixed dose combinations (FDC) is associated with a better likelihood of HbA1c goal attainment and lower health care resource use and costs.

Setareh A. Williams, PhD
Erin K. Buysman, MS
Erin M. Hulbert, MS
Joette Gdovin Bergeson, PhD
Bin Zhang, MD

Editor’s Memo
John Marcille
The new schedule will burden health plans with extra costs, but will also allow a smoother transition
Ray Desrochers
Legislation & Regulation
Attempts to force hospitals to make prices public often fail for lack of standardization
John Carroll
Plan Watch

Though ROI is hard to calculate, insurer says that its on-site clinics are changing employee behavior for the good

Frank Diamond
Tomorrow’s Medicine

A tiny new implantable heart pump transmits speed, power consumption, and blood flow data directly to the cardiac center

Thomas Morrow, MD